6-H2

N/A

Report date: 2024/03/25 15:27:25

Base Information

Drug Name6-H2
Drug Alias Name6H26-H2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFatty acid-binding protein, adipocyte inhibitors
TargetsFatty acid-binding protein, adipocyte
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Hong Kong
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Hong Kong
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A